CERo Therapeutics Holdings Inc (NASDAQ: CERO) started the day on Thursday, with a price increase of 10.69% at $0.19, before settling in for the price of $0.17 at the close. Taking a more long-term approach, CERO posted a 52-week range of $0.06-$12.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. This publicly-traded company’s shares outstanding now amounts to $147.54 million, simultaneously with a float of $26.22 million. The organization now has a market capitalization sitting at $28.78 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1317, while the 200-day Moving Average is $0.7845.
CERo Therapeutics Holdings Inc (CERO) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. CERo Therapeutics Holdings Inc’s current insider ownership accounts for 48.94%, in contrast to 4.24% institutional ownership. According to the most recent insider trade that took place on Sep 25 ’24, this organization’s 10% Owner sold 532,486 shares at the rate of 0.10, making the entire transaction reach 55,538 in total value, affecting insider ownership by 21,067,956. Preceding that transaction, on Oct 10 ’24, Company’s 10% Owner sold 3,250,000 for 0.10, making the whole transaction’s value amount to 325,000. This particular insider is now the holder of 22,620,783 in total.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Let’s observe the current performance indicators for CERo Therapeutics Holdings Inc (CERO). It’s Quick Ratio in the last reported quarter now stands at 0.39. The Stock has managed to achieve an average true range (ATR) of 0.05.
In the same vein, CERO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
If we take a close look at the recent performances of CERo Therapeutics Holdings Inc (NASDAQ: CERO), its last 5-days Average volume was 6.24 million that shows plunge from its year to date volume of 20.44 million. During the previous 9 days, stock’s Stochastic %D was recorded 29.49% While, its Average True Range was 0.0459.
Raw Stochastic average of CERo Therapeutics Holdings Inc (CERO) in the period of the previous 100 days is set at 33.30%, which indicates a major rise in contrast to 16.44% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 279.15% that was higher than 240.40% volatility it exhibited in the past 100-days period.
